Skip to main content
. 2019 Dec 9;9:18639. doi: 10.1038/s41598-019-54867-8

Table 2.

Meta-analysis of published literature, addressing mortality trends in osteoarthritis patients.

# PMID N HR # PMID N HR
Meta-analysis of published literature
1 30169829[d] 5.2 × 104 1.3/1, K-RKOA 18 20416065 2163 0.92 HRE
2 29588472*[sec] 809 0.76/1.1 HRE/KRE 19 17540743 6.4 × 104 0.77 HRE, KRE < 12 years follow up
3 28754502 601 1.97 K 20 12784389 2.35 × 106 1.0 OA
4 28607349[w] 1025 1.98 K 21 12525385 7200 1.1 H
5 27866950 4278 0.86 KRE/HRE 22 10743987 3.9 × 104 0.73 HRE
6 26543059 821 (K), 806(H) 2.0, 1.0 K/H 23 28375889* 7.1 × 105 0.6 HRE/KRE
7 26986874[d] 5.2 × 105 0.9 K, HP 24 29489471* 1.3 × 105 0.98 HRE
8 17462546[ed] 7.4 × 105 0.72 25 26704362 5853 0.9 SAR
9 26777550* 3625 0.81 KRE/HRE 26 29158649 358 0.91 KRE
10 26751980* 9443 0.73 (K, <10 years follow up), 1.9 (>20 years follow up) 27 26871792* 3.6 × 105 0.84 (at 5 years follow up), 1.1 (>10 years follow up)
11 24047870 1348 1.0 H 28 28754502 601 1.97 K
12 25778744 7889 1.14 HP 29 25179456 850 0.5 OA
13 25819581 1025 1.6 K 30 21385807 1163 1.55 OA
14 24608134 2125 1.27 K 31 21282754 1.7 × 105 0.7 HRE
15 15252092 8000 1.32 H 32 24158755 1290 1.4 OA
16 doi: 10.1093/rheumatology/kez108.062 8066 1.18 H, K 33 30583096 4182 1.15 K
17 30559011* 4907

0.95 HRE

1.45 HRE

34 30302017* 1.3 × 106

0.65 (3 years)

0.85 (7 years), HRE, KRE

Meta-analysis of literature includes PubMed ID number of the source (PMID), the size of the study (N), the average hazard ratio in sub-cohorts (HR) for all-cause mortality in OA, K – knee generic, RKOA – knee radiographic, KSR – knee self-reported, H - hand generic, HP – hip generic, HRE – hip replacement, KRE- knee replacement, OA – osteoarthritis generic, SAR – shoulder arthroplastic, SEC – secondary, P – primary.

*The publications describing initial decrease of all-cause mortality followed by subsequent increase; [w] The publications describing the effect of decreased mobility associated with knee OA on all-cause mortality, [ed] Mutual exclusion of diseases, [d] Reductions in selected co-morbidities vs. control.